Sunesis Pharmaceuticals

Biotechnology Research • South San Francisco, California, United States • 21-50 Employees

Company overview

Headquarters	395 Oyster Point Blvd., Ste. 400, South San Francisco, CA 94080, US
Phone number	+16502663500
Website	sunesis.com
NAICS	541714
Founded	1987
Employees	21-50
Socials

Key Contact at Sunesis Pharmaceuticals

Cindy Lopez

Senior Director, Regulatory Affairs

Sunesis Pharmaceuticals Email Formats

Sunesis Pharmaceuticals uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	45.6%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	22.3%
{first name}@company.com	john@company.com	15.1%
{first name}{last name}@company.com	johndoe@company.com	9.8%
{first name}_{last name}@company.com	john_doe@company.com	7.2%

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and future commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. Sunesis has built an experienced cancer drug development organization committed to improving the lives of people with cancer. The company is focused on advancing its novel kinase-inhibitor pipeline, with an emphasis on establishing proof of concept that it's oral non-covalent BTK inhibitor, vecabrutinib (SNS-062), is effective in the treatment of ibrutinib-resistant chronic lymphocytic leukemia. The commitment to advancing oncology treatment and patient care is paramount at Sunesis, and it drives every aspect of our business. • Our work—pursuing the best possible translational and clinical science to ensure that we deliver important new drugs to patients • Our workplace—creating a stimulating, teamwork-oriented environment for our people involved in this important work • Our world—supporting the larger oncology community and the philanthropic organizations that help patients and caregivers

Sunesis Pharmaceuticals revenue & valuation

Annual revenue	$120,000
Revenue per employee	$3,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$384,000
Total funding	$25,000,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Sunesis Pharmaceuticals has 17 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Sunesis Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2016-11-19	14	$25,000,000

Funding Insights

$25,000,000

Total funding amount

$25,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Sunesis Pharmaceuticals is located in South San Francisco, California, US.

You can reach Sunesis Pharmaceuticals at +16502663500.

Sunesis Pharmaceuticals was founded in 1987, making it 39 years old. The company has established itself as a significant player in its industry over this time.

Sunesis Pharmaceuticals has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Sunesis Pharmaceuticals has raised a total of $25,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Sunesis Pharmaceuticals

Cindy Lopez

Senior Director, Regulatory Affairs

4.8

40,000 users